Omalizumab in patients with severe asthma and persistent sputum eosinophilia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1710-1492

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Omalizumab in patients with severe asthma and persistent sputum eosinophilia ; volume:15 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-5 ; date:12.2019
Allergy, asthma and clinical immunology ; 15, Heft 1 (3.4.2019), 1-5, 12.2019

Classification: Medizin, Gesundheit

Creator: Mukherjee, Manali
Kjarsgaard, Melanie
Radford, Katherine
Huang, Chynna
Leigh, Richard
Dorscheid, Delbert R.
Lemiere, Catherine
Boulet, Louis-Philippe
Waserman, Susan
Martin, James
Nair, Parameswaran

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13223-019-0337-2

URN: urn:nbn:de:101:1-2019042401225232753501

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mukherjee, Manali
Kjarsgaard, Melanie
Radford, Katherine
Huang, Chynna
Leigh, Richard
Dorscheid, Delbert R.
Lemiere, Catherine
Boulet, Louis-Philippe
Waserman, Susan
Martin, James
Nair, Parameswaran
SpringerLink (Online service)

Other Objects (12)

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Hochschulschrift

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Hochschulschrift

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Hochschulschrift

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Blood and sputum eosinophilia in COPD exacerbation

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

Severe asthma and the omalizumab option

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer

Sputum-ECP bei Asthma bronchiale

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Autoinflammatory gene mutations associated with eosinophilia and asthma

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung

Related objects

Reset password